期刊文献+

p38 MAPK信号通路在小胶质细胞激活介导多巴胺能神经元变性中的作用研究 被引量:2

Role of p38 mitogen-activated protein kinase in activated microglia-mediated the degeneration of dopaminergic neurons
下载PDF
导出
摘要 目的:研究p38丝裂原激活蛋白激酶(p38MAPK)在脂多糖(LPS)诱导小胶质细胞激活介导多巴胺(DA)能神经元变性中的作用。方法:脑立体定位注射LPS于大鼠脑黑质,Western blot印记法检测不同时间点(0、0.5h、1h、6h、12h)黑质p38磷酸化水平。酪氨酸羟化酶(Tyrosine hydroxylase,TH)免疫组织化学染色观察蛋白激酶(MAPK)特异性抑制剂SB203580预处理后LPS对DA能神经元变性的影响。结果:黑质注射LPS后,Western blot结果显示p38MAPK总体蛋白水平在各组均存在表达,无显著性差异(P>0.05),而其磷酸化p-p38MAPK却发生了明显变化。正常对照组和PBS注射侧几乎无p-p38的表达,LPS注射后30min,p-p38即有少量的表达;1h表达量增加;6h表达量达高峰;12h后表达量逐渐下降。与PBS对照侧相比,LPS注入黑质导致TH阳性细胞数下降至38%;SB203580预处理可以显著增加TH+细胞数达63%(P<0.05)。结论:p38MAPK信号通路参与了LPS诱导小胶质细胞激活介导DA能神经元变性,可通过阻断信号通路来减轻LPS诱导DA能神经元变性,为PD治疗提供新的思路。 Objective: To study the role of p38 mitogen-activated protein kinase(p38MAPK) on the degeneration of dopaminergic neurons induced by intranigral injection of Lipopolysaecharide (LPS). Methods: LPS was stereotaxically injected into substantia nigra(SN), p38phosphorylation levels at different survival times(0,0.5h, 1h,6h, 12h)were determined by Western-blot. The effect of LPS on the s ubstantia nigral DA neurons after specific inhibitor SB203580 pretreatment was observed by using(Tyrosine hydroxylase,TH ) immnohistochernical staining. Results: Western blot analysis revealed that there was no significant difference of Total p38MAPK in all groups. Level of phosphorylation of p38MAPK (p-p38) was a little upregulated in the ipsilateral SN as early as 30min after LPS and increased at lh. It reached the maximal level at 6h and returned to the basal level at 12h. Compared with PBS control side, TH positive neurons in the SN decreased by 68%, TH-positive neurons in the SN precondhioned by specific inhibitor SB203580 increased significantly. Conclusions: p38MAPK plays an important role in the activation of microglia by LPS and inhibition of the signal transduction pathway may consequently be an effective approach to decrease the degeneration of DA neurons by I.PS for the treatment of PD.
出处 《脑与神经疾病杂志》 2006年第2期105-107,104,共4页 Journal of Brain and Nervous Diseases
基金 国家自然科学基金资助(30500574)
关键词 脂多糖 多巴胺能神经元 小胶质细胞 丝裂原激活蛋白激酶 SB203580 Lipopolysaccharide Dopaminergic neurons Mieroglia Mitogen-activated protein kinase SB203580
  • 相关文献

参考文献13

  • 1孙圣刚,黎钢,曹学兵,童萼塘.帕金森病与炎症反应关系研究进展[J].中华神经科杂志,2003,36(6):401-403. 被引量:25
  • 2Wang MJ,Lin WW,Chen HL,et al.Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation.Eur J Neurosci,2002,16:2103~2112
  • 3Jeohn GH,Cooper CL,Wilson B,et al.p38 MAP kinase is involved in Lipopolysaccharide-induced dopaminergic neuronal cell death in rat mesencephalic neuron-glia cultures.Ann.N.Y.Acad.Sci,2002,962:332~346
  • 4Shibata H,Kasuki H,Nishiwaki M,et al.Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures:role of inducible nitric oxide synthase and protection by indomethacin.J Neurochem,2003,86:1201~1212
  • 5Mirza BH,Thomesn HP,Moos T.The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.Neuroscience,2000,95:425~432
  • 6Wu DC,Jackson V,Vila M,et al.Blockade of microglia activation is neuroprotective in the MPTP mouse model of Parkinson disease.J Neurosci,2002,22:1763~1771
  • 7He Y,Appel S,and Le W.Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.Brain Res,2001,909:187~193
  • 8Sheer TB,Betarbet R,Kim JH,et al.Selective microglia activation in the rat rotenone model of Parkinson's disease.Neurosci Lett,2003,341:87~90
  • 9Kim WG,Mohney RP,Wilson B,et al.Regional difference in susceptibility to Lipopolysaccharide-induced neurotoxicity in the rat brain:role of microglia.J Neuorsci,2000,20:6309~6316
  • 10黎钢,孙圣刚,董大翠,曹学兵,胡波,童萼塘.脂多糖诱导黑质多巴胺能神经元变性中小胶质细胞的反应[J].中国组织化学与细胞化学杂志,2003,12(3):250-254. 被引量:8

共引文献29

同被引文献24

  • 1师亮,张宇新,张作凤,陈浩.COX-2对帕金森病小鼠黑质内多巴胺能神经元的毒性作用[J].第四军医大学学报,2006,27(18):1661-1664. 被引量:9
  • 2杨海东,姜宏,宋宁,王俊,谢俊霞.人参皂苷Rg_1对MPTP致帕金森病模型小鼠多巴胺能神经元保护作用研究[J].解放军药学学报,2007,23(1):17-21. 被引量:13
  • 3Hald A, Lotharius J. Oxidative stress and inflammation in Parkinson's disease: Isthere a causallink [J]? Exp Neurol, 2005, 193 (2): 279-90.
  • 4Roux PP, Blenis John. ERK and p38 MAPK-Activated Protein Kinases: a family protein kinases with diverse biological functions [J]. Microbio Mole Biol Rev, 2004, 68(2): 320-44.
  • 5Smeyne RJ, Jackson-Lewis V. The MPTP model of Parkinson's diseaseIJ ]. Brain Res Mol Brain Res, 2005, 134 (1): 57-66.
  • 6Marchetti B, Abbracchio MP. To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy ofneurodegenemtive disorders [J]. Trends Pharmacol Sci, 2005, 26 (10): 517-25.
  • 7Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain disease[J]. Neuropathol Exp Neurol, 2004, 63 (9):901-10.
  • 8Wang T, Pei Z, Zhang W, et al. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration [J]. FASEB J, 2005, 19(9): 1134-6.
  • 9Degousee N, Martindale J, Stefanski E, et al. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo[J]. Circ Res, 2003, 92( 1 ): 757-64.
  • 10Zhang JT. Retrospect and prospect of ginseng research [J]. Acta Pharm Sin, 1995, 30(5): 321

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部